Cure My Disease

Don't miss your cure!

 Log in / Sign up

Bladder cancer treatment at home? new study tests feasibility

NCT ID NCT07048496

Recruiting now Knowledge-focused Sponsor: Abramson Cancer Center at Penn Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether giving BCG therapy for non-muscle invasive bladder cancer at home is feasible and effective. It includes two groups: one to understand barriers to treatment compliance, and another to test a home BCG program with a chatbot that tracks symptoms and quality of life. The goal is to see if patients can successfully complete their treatments at home rather than in a clinic.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
BCG (Bacillus Calmette-Guérin) delivered at home
What this could lead to
If successful, this could show that home-based BCG treatment is a practical option, potentially improving convenience and adherence for bladder cancer patients.
What could go wrong
This is a small pilot study (50 participants) focused on feasibility, not on curing or controlling the disease. The results may not apply to all patients, and home treatment could pose safety or logistical challenges.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

  • Abramson Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.